Your browser doesn't support javascript.
loading
Angioedema hereditario, ponderación de evidencias. parte 2 - tratamiento / Hereditary angioedema, weighting of evidence. Part 2 - Treatment
Arch. alerg. inmunol. clin ; 48(1): 21-25, 2017.
Article in Spanish | LILACS | ID: biblio-914820
RESUMEN
Desde las observaciones de Quincke y Osler, que refirieron pacientes con una "tumefacción" diferente de las que provocaban habitualmente los mecanismos alérgicos hasta el descubrimiento de un nuevo mediador responsable de esos edemas dolorosos y deformantes, se han sucedido los aportes de los investigadores en el esclarecimiento de la patogenia y el tratamiento del AEH hasta la actualidad, en que el arsenal terapéutico se ve notablemente enriquecido por medicamentos altamente eficaces y específicos. Intentaremos describirlos. (AU)
ABSTRACT
From the observations of Quincke and Osler, who referred patients with a "swelling" different from those that usually provoked the allergic mechanisms until the discovery of a new mediator responsible for these painful and deforming edemas, have been the contributions of researchers in the Clarification of the pathogenesis and treatment of HAE to date, where the therapeutic arsenal is remarkably enriched by highly effective and specific drugs. We will try to describe them.(AU)
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Angioedemas, Hereditary Limits: Humans Country/Region as subject: South America / Argentina Language: Spanish Journal: Arch. alerg. inmunol. clin Journal subject: Allergy and Immunology Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Angioedemas, Hereditary Limits: Humans Country/Region as subject: South America / Argentina Language: Spanish Journal: Arch. alerg. inmunol. clin Journal subject: Allergy and Immunology Year: 2017 Type: Article